Viewing StudyNCT03215511



Ignite Creation Date: 2024-05-06 @ 10:16 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03215511
Status: COMPLETED
Last Update Posted: 2024-03-26
First Post: 2017-06-30

Brief Title: A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer
Sponsor: Bayer
Organization: Bayer

Conditions & Keywords Data

Conditions:
Name
Solid Tumors Harboring NTRK Fusion
Keywords:
Name View
Children View
Solid Tumor View
Metastatic cancer View
Advanced cancer View
Neurotrophic tyrosine receptor kinase NTRK View
NTRK1 View
NTRK2 View
NTRK3 View
Fusion Positive View